Galena Biopharma Inc (GALE)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Galena Biopharma Inc (GALE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012963
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Galena Biopharma Inc (Galena) is a biopharmaceutical company that develops and markets therapies for the treatment of unmet medical needs and advance care. The company’s pipeline products comprise NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 and GALE-301 folate binding protein for the treatment of breast cancer, gastric cancer, endometrial and ovarian cancer. The company develops drugs through mid-to-late-stage clinical assets led by hematology care programs. It has collaborations with cancer institutions, cancer centers and pharmaceutical and life science companies. Galena is headquartered in San Ramon, California, the US.

Galena Biopharma Inc (GALE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Galena Biopharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galena Biopharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Galena Biopharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galena Biopharma Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Galena Biopharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Galena Biopharma Inc, Medical Equipment, Deal Details 10
Partnerships 10
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 10
Equity Offering 11
Galena Biopharma Raises Up to USD15.5 Million in Public Offering of Shares and Warrants 11
Galena Biopharma to Raise Funds in Public Offering of Shares 13
Galena Biopharma Raises USD12.6 Million in Private Placement of Shares and Warrants 14
Galena Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares and Warrants for USD43 Million 15
Galena Biopharma Inc – Key Competitors 17
Galena Biopharma Inc – Key Employees 18
Galena Biopharma Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Nov 09, 2017: Galena Biopharma Reports Third Quarter 2017 Financial Results 20
Aug 14, 2017: Galena Biopharma Reports Second Quarter 2017 Financial Results 22
May 10, 2017: Galena Biopharma Reports First Quarter 2017 Financial Results 25
Mar 15, 2017: Galena Biopharma Reports Fourth Quarter and Year End 2016 Financial Results and Provides a Corporate Update 28
Nov 09, 2016: Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update 32
Aug 09, 2016: Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update 35
May 10, 2016: Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a Corporate Update 38
Mar 10, 2016: Galena Biopharma Reports Fourth Quarter and Year End 2015 Financial Results and Provides a Corporate Update 41
Corporate Communications 42
Feb 21, 2017: Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer 42
Jan 31, 2017: Galena Biopharma Announces the Resignation of its President and Chief Executive Officer and the Evaluation of Strategic Alternatives 43
Nov 03, 2016: Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer 44
Apr 26, 2016: Galena Biopharma Appoints Mary Ann Gray, Ph.D., to Its Board of Directors 45
Legal and Regulatory 47
Feb 16, 2016: Galena Biopharma Announces Proposed Settlement of Derivative Litigation 47
Other Significant Developments 48
Jul 12, 2017: Galena Biopharma Provides Corporate Update 48
Jan 05, 2017: Galena Biopharma to Provide Corporate and Clinical Update and 2017 Outlook During Presentation at Biotech Showcase 2017 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Galena Biopharma Inc, Medical Equipment, Key Facts, 2016 2
Galena Biopharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Galena Biopharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galena Biopharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Galena Biopharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galena Biopharma Inc, Deals By Market, 2011 to YTD 2017 8
Galena Biopharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 10
Galena Biopharma Raises Up to USD15.5 Million in Public Offering of Shares and Warrants 11
Galena Biopharma to Raise Funds in Public Offering of Shares 13
Galena Biopharma Raises USD12.6 Million in Private Placement of Shares and Warrants 14
Galena Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares and Warrants for USD43 Million 15
Galena Biopharma Inc, Key Competitors 17
Galena Biopharma Inc, Key Employees 18
Galena Biopharma Inc, Subsidiaries 19

★海外企業調査レポート[Galena Biopharma Inc (GALE)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inivata Ltd:製品パイプライン分析
    Summary Inivata Ltd (Inivata) is a clinical cancer genomics company that utilizes the precision of circulating tumor DNA analysis to improve personalized healthcare in oncology. The company uses liquid biopsy platform, to identify and characterize ctDNA through a non-invasive blood test. Its liquid …
  • OGE Energy Corp (OGE):企業の財務・戦略的SWOT分析
    OGE Energy Corp (OGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • UniCredit S.p.A:戦略・SWOT・企業財務分析
    UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report Summary UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tate & Lyle PLC:企業のM&A・事業提携・投資動向
    Tate & Lyle PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tate & Lyle PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Patterson-UTI Energy Inc (PTEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Patterson-UTI Energy Inc (Patterson) is an oilfield service provider. It offers onshore contract drilling and pressure pumping services to oil and gas exploration and production companies. The company offers pressure pumping services such as well stimulation and cementing for completion of n …
  • Great Wolf Resorts Inc:企業の戦略・SWOT・財務情報
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ionis Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Ionis Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ionis Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • PT Tiphone Mobile Indonesia Tbk (TELE):企業の財務・戦略的SWOT分析
    PT Tiphone Mobile Indonesia Tbk (TELE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Denovo Biopharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Denovo Biopharma LLC (Denovo Biopharma), formerly Denovo Biomarkers Inc is a biotechnology company that provides novel biomarker solutions to personalize drug development. The company enables drug developers to design new clinical trials in targeted patient population and re-evaluates medici …
  • Dexia Group:企業のM&A・事業提携・投資動向
    Dexia Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexia Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Rakuten, Inc. (4755):企業の財務・戦略的SWOT分析
    Rakuten, Inc. (4755) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Solvay SA (SOLB):電力:M&Aディール及び事業提携情報
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates. In addition, the company manufactures additives, engineering plastics, diphenols an …
  • Stavropolenergosbyt (STSB):電力:M&Aディール及び事業提携情報
    Summary Stavropolenergosbyt, a subsidiary of Novgorodskaya energosbytovaya kompaniya is an energy and power company that supplies and distributes electricity. The company provides services such as electricity distribution, energy survey, payment information, energy audit and inspection and energy sa …
  • CalAmp Corp. (CAMP):企業の財務・戦略的SWOT分析
    CalAmp Corp. (CAMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Alucon Public Company Limited:戦略・SWOT・企業財務分析
    Alucon Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Alucon Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cyclopharm Ltd (CYC):企業の財務・戦略的SWOT分析
    Cyclopharm Ltd (CYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nissan Chemical Corporation:企業の戦略・SWOT・財務分析
    Nissan Chemical Corporation - Strategy, SWOT and Corporate Finance Report Summary Nissan Chemical Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • FOCUS Brands Inc.:企業の戦略・SWOT・財務情報
    FOCUS Brands Inc. - Strategy, SWOT and Corporate Finance Report Summary FOCUS Brands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • NTT Data Corporation:企業のM&A・事業提携・投資動向
    NTT Data Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NTT Data Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Atradius NV:企業の戦略的SWOT分析
    Atradius NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆